A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2001
11/07/2001	EP1151121A1 Recombined porcine adenovirus based viral vaccines and vectors
11/07/2001	EP1151107A1 Basb059 polypeptides from neisseria meningitidis
11/07/2001	EP1151101A1 Prostacyclin-stimulating factor-2
11/07/2001	EP1151010A2 Human polyclonal antibodies from transgenic nonhuman animals
11/07/2001	EP1151009A2 Antimicrobial/endotoxin neutralizing polypeptide
11/07/2001	EP1151000A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/07/2001	EP1150991A2 Compositions for treating inflammatory response
11/07/2001	EP1150990A1 Erythromycin a compounds and process for preparing the same
11/07/2001	EP1150988A1 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
11/07/2001	EP1150982A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND I$g(k)-A$g(a)
11/07/2001	EP1150981A1 Therapeutic nucleoside compound
11/07/2001	EP1150973A1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
11/07/2001	EP1150965A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
11/07/2001	EP1150960A1 Polymorphic crystalline forms of celecoxib
11/07/2001	EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability
11/07/2001	EP1150950A2 Anthranilic acid derivatives
11/07/2001	EP1150948A1 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
11/07/2001	EP1150939A1 Nephronin: a series of compounds for treatment of infectious diseases and cancer
11/07/2001	EP1150713A2 Vaccine formulation comprising monoglycerides or fatty acids as adjuvant
11/07/2001	EP1150712A2 Human papilloma virus vaccine formulations
11/07/2001	EP1150711A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence
11/07/2001	EP1150710A1 Immunogenic complexes and methods relating thereto
11/07/2001	EP1150707A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS
11/07/2001	EP1150706A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response
11/07/2001	EP1150702A2 Utilization of orosomucoid in order to produce a pharmaceutical preparation
11/07/2001	EP1150693A1 Immunogenic compositions for use as vaccines
11/07/2001	EP1150690A1 Chemical compounds
11/07/2001	EP1150689A1 Chemical compounds
11/07/2001	EP1150686A1 Directly compressible matrix for controlled release of single daily doses of clarithromycin
11/07/2001	EP1150666A1 Stimulating neutrophil function to treat inflammatory bowel disease
11/07/2001	EP1150665A2 Use of statins for treating viral infections
11/07/2001	EP1150658A2 Method for controlling liposome size
11/07/2001	EP0861235B1 Substituted benzylaminopiperidine compounds
11/07/2001	EP0799039B1 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
11/07/2001	EP0751789B1 Gel for treatment of skin diseases and for disinfection of the skin
11/07/2001	EP0702560B1 Immunologic enhancement with intermittent interleukin-2 therapy
11/07/2001	CN1321190A i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene
11/07/2001	CN1321165A Prevention and treatment of viral disease
11/07/2001	CN1321082A Micronised pharmaceutical compositions
11/07/2001	CN1321080A Fast dissolving orally consumable films
11/07/2001	CN1320597A Antifungal and its preparation method and intermediate
11/07/2001	CN1320438A Process for preparing medicines
11/07/2001	CN1320437A Chinese-medicinal herbs cigarette
11/07/2001	CN1320422A Process for preparing Chinese-medicinal pills containing borneol
11/07/2001	CN1320421A Freeze dried preparation of bacteriophagic Bdellovibrio and its preparing process
11/07/2001	CN1074422C Method for preparing HCV epitope-contg. separated polypeptide
11/06/2001	US6313311 Imidazole derivatives having affinity for alpha2 receptors
11/06/2001	US6313307 Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings
11/06/2001	US6313299 Antibacterial agents effective against methicillin resistant staphylococcus and streptococcus; 1,8-naphthrydine derivatives
11/06/2001	US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment
11/06/2001	US6313281 Nucleic acid encoding OMP26 antigen from Haemophilus influenzae
11/06/2001	US6313270 DbpB
11/06/2001	US6313269 Tumor necrosis factor related receptor, TR6
11/06/2001	US6313214 Melanin inhibiting and cell growth activating compositions containing compounds having labdane structure
11/06/2001	US6313178 For inhibit the growth of mycobacterium avium complex, in cancer therapy
11/06/2001	US6313177 As antiviral agents
11/06/2001	US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
11/06/2001	US6313127 For therapy of hypercholesterolemia or atherosclerosis
11/06/2001	US6313116 Phosphodiesterase inhibitors
11/06/2001	US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
11/06/2001	US6313101 Antibiotics
11/06/2001	US6313100 Antibacterial, antiprotozoa agents
11/06/2001	US6312939 Cells; for use in treatment of tumors, lung, breast and colon cancer and the treatment of preferential viral diseases
11/06/2001	US6312907 An isolated nucleic acid encoding a gene for decorin binding protein from borrelia; diagnosis and therapy of lyme disease in humans and animals
11/06/2001	US6312753 Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses
11/06/2001	US6312696 Isolated dna molecules with polypeptide codes and amino acid sequences
11/06/2001	US6312689 Antibodies or antigens
11/06/2001	US6312665 Aerosol formulations for buccal and pulmonary application
11/03/2001	CA2345760A1 Pharmaceutical uses for fluoroalkoxybenzylamino and alkoxybenzylamino derivatives of nitrogen containing heterocycles
11/02/2001	CA2314494A1 Anionic polymers as species specific antibacterial agents
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081574A2 Regulation of nf-at interacting protein nip 45 variant
11/01/2001	WO2001081554A1 Pneumovirus ns proteins antagonising the interferon (ifn) response
11/01/2001	WO2001081422A1 Secretory tyrosine phosphatases from mycobacteria
11/01/2001	WO2001081380A2 Immunogenic pneumococcal protein and vaccine compositions thereof
11/01/2001	WO2001081376A2 Apo-ai/aii peptide derivatives
11/01/2001	WO2001081373A2 Glycopeptide antibacterial compounds and methods of using same
11/01/2001	WO2001081372A2 Vancomycin analogs
11/01/2001	WO2001081363A1 Novel compounds
11/01/2001	WO2001081359A1 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
11/01/2001	WO2001081358A1 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals
11/01/2001	WO2001081350A1 Oxazolidinone derivatives with antibiotic activity
11/01/2001	WO2001081348A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO[3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS
11/01/2001	WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
11/01/2001	WO2001081340A2 Heterocycles that are inhibitors of impdh enzyme
11/01/2001	WO2001081325A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties
11/01/2001	WO2001081323A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/01/2001	WO2001081318A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
11/01/2001	WO2001081310A1 1-aroyl-piperidinyl benzamidines
11/01/2001	WO2001080886A2 Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof
11/01/2001	WO2001080883A1 Bispecific molecules and uses thereof
11/01/2001	WO2001080877A1 Preventives for reinfection after liver transplantation
11/01/2001	WO2001080858A1 Stable liquid preparation
11/01/2001	WO2001080856A2 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
11/01/2001	WO2001080840A2 Cytotoxic agents comprising single-stranded and/or looped dna
11/01/2001	WO2001080839A2 Use of naphthindazole-4,9-quinones as antiparasitic agents
11/01/2001	WO2001080838A2 Use of n2-substituted benz[f]indazole-4,9-quinones as antiparasitic agents
11/01/2001	WO2001080836A1 Use of particulate vectors in immunomodulation
11/01/2001	WO2001080823A2 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients

1 ... 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 ... 1798